𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer

✍ Scribed by Lamana, M L; Bueren, J A; Vicario, J L; Balas, A

Book ID
110039483
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
409 KB
Volume
11
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Induction of T cell tolerance to a prote
Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer
✍ Chaorui Tian; Jessamyn Bagley; Joel Kaye; Dr John Iacomini πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 149 KB

## Abstract ## Background Host immune responses to foreign gene products have been shown to lead to the elimination of genetically modified cells, and are a major barrier to successful therapeutic gene therapy. We have shown that immunological tolerance to retrovirally transduced cell surface prot

Retroviral-mediated gene transfer of CSF
Retroviral-mediated gene transfer of CSF-1 into op/op stromal cells to correct defective in vitro osteoclastogenesis
✍ Sherry L. Abboud; Kathleen A. Woodruff; Goutam Ghosh Choudhury πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 3 views

Colony-stimulating factor-1 (CSF-1) released by stromal cells in the bone microenvironment is essential for the proliferation of osteoclast progenitors. In op/op mutant mice, a thymidine insertion in the coding sequence of the CSF-1 gene results in CSF-1 deficiency that in turn leads to decreased os

Tissue-specific growth suppression and c
Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene
✍ G W Xu; Z T Sun; K Forrester; X W Wang; J Coursen; C C Harris πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 646 KB

HCC patients are generally resistant to chemotherapy, Selective expression of cytotoxic gene products in tuwhich, in some cases, may be the result of a loss of function mor cells is one of the goals of gene therapy for treating mutation in the p53 gene. cancer. We are developing such a strategy for